Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,790,805
-$22,228,245 QoQ
Shares Held
1,647,647
-58.8% QoQ
Ownership
0.736%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Derivatives in ADMA
reported options exposure · as of Sep 30, 2025CallValue
$332,782
CallShares
22,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ADMA ranks #99 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ADMA
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,790,805 | 1,647,647 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $36,019,050 | 3,997,675 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $35,136,383 | 1,926,337 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $16,487,746 | 1,124,676 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $332,782 | 22,700 | Call | Defined | 2026-02-03 | |
| 2025-06-30 | $413,367 | 22,700 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $22,014,777 | 1,208,939 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,923,214 | 701,775 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $13,140,739 | 766,224 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,883,856 | 244,315 | Shares | Defined | 2025-03-18 | |
| 2024-06-30 | $9,957,599 | 890,662 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,922,894 | 594,378 | Shares | Defined | 2025-03-18 | |
| 2023-12-31 | $6,307,852 | 1,395,543 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,524,287 | 1,263,768 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,440,317 | 1,474,341 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,134,666 | 1,853,374 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,724,620 | 1,217,686 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,331,105 | 959,303 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,265,091 | 638,936 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,824,353 | 996,915 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $893,006 | 633,339 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $549,642 | 486,411 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $785,315 | 490,823 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $879,743 | 499,855 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $26,676 | 13,681 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $224,088 | 93,761 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $56,506 | 19,286 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $27,209 | 9,448 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||